After successful treatment of wet AMD, in what patients would retina specialists continue to treat dry AMD and what treatment should be used?

Williams, George A.
January 2011
Ocular Surgery News;1/25/2011, Vol. 29 Issue 2, p11
Academic Journal
The article recommends keeping patients on vitamins, as outlined by the Age-Related Eye Disease Study (AREDS), after they have developed neovascularization to slow down the progression of atrophic age-related macular degeneration (AMD) following successful treatment of wet AMD.


Related Articles

  • After successful treatment of wet AMD, in what patients would retina specialists continue to treat dry AMD and what treatment should be used? Kim, Judy E. // Ocular Surgery News;1/25/2011, Vol. 29 Issue 2, p11 

    The article recommends several treatment options for dry age-related macular degeneration (AMD) following successful treatment of wet AMD, including continuing monthly anti-vascular endothelial growth factor (VEGF) treatments to manage eyes treated for exudative AMD.

  • Eccentric viewing.  // Community Eye Health Journal;Mar2012, Vol. 25 Issue 77, p8 

    The article explains that people with loss of central vision, often associated with macular degeneration, will need to develop an eccentric viewing technique, where they use their peripheral vision instead of their central vision; a web resource on how to use eccentric viewing is provided.

  • Choroidal neovascularisation complicating geographic atrophy in age-related macular degeneration. Querques, Giuseppe; Massamba, Nathalie; Coscas, Florence; Forte, Raimondo; Souied, Eric H. // British Journal of Ophthalmology;Dec2012, Vol. 96 Issue 12, p1479 

    Objective To investigate the morphological and functional outcomes after intravitreal ranibizumab injections for choroidal neovascularisation (CNV) complicating geographic atrophy (GA). Design Retrospective, interventional, consecutive case series. Methods We reviewed the charts of all...

  • Macular Degeneration: From Diagnosis to Treatment. Ham, Kelli; Darling, Louise M. // Consumer Connections;2012, Vol. 28 Issue 4, p1 

    No abstract available.

  • The COMPLETE Trial For Dry AMD: Results. Regillo, Carl; Cunningham, EmmettT.; Duker, Jay S. // Review of Ophthalmology;Sep2012, Vol. 19 Issue 9, p56 

    The article focuses on the complete trial of systemic complement inhibition for dry age (DA)-related macular degeneration treated with eculizumab. It says that the eculizumab is given in 900 milligram (mg) weekly for four weeks, 600 mg for four weeks, and placebo or saline for four weeks. The...

  • Viagra Arouses More Attention.  // Review of Ophthalmology;Jul2000, Vol. 7 Issue 7, p18 

    Reports on the study conducted by researchers from the University of Texas Health Science Center which revealed that Viagra may offer potential treatment for patients with macular degeneration.

  • Dissecting the Promise of PDT. McDermott, Gilliam K. // Review of Ophthalmology;Aug2000, Vol. 7 Issue 8, p73 

    Investigates photodynamic therapy (PDT) in the treatment of age-related macular degeneration. Advantages of PDT over standard laser treatment involving the photocoagulation of the choroidal neovascular membranes of the retina; Photosensitizing agents used in PDT; Safety of the procedure;...

  • A Fresh Look at Drug Delivery. Ambati, Jayakrishna; Adamis, Anthony P.; Regillo, Carl; T-Cunningham Jr, Emmett // Review of Ophthalmology;Aug2001, Vol. 8 Issue 8, p74 

    Focuses on the development of drug therapy and delivery systems for retinal choroidal neovascularization in age-related macular degeneration and diabetic retinopathy. Causes of vision loss in diabetic retinopathy; Development of anti-angiogenic agents; Role of prinomastat in the remodeling of...

  • ARMD: Treatment and prevention. Silverstone, Dede // Ophthalmology Times;2/13/95, Vol. 20 Issue 7, p9 

    Reports on treatment and prevention of age-related macular degeneration. Photodynamic therapy.


Read the Article


Sign out of this library

Other Topics